NL1044086A - Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement - Google Patents
Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement Download PDFInfo
- Publication number
- NL1044086A NL1044086A NL1044086A NL1044086A NL1044086A NL 1044086 A NL1044086 A NL 1044086A NL 1044086 A NL1044086 A NL 1044086A NL 1044086 A NL1044086 A NL 1044086A NL 1044086 A NL1044086 A NL 1044086A
- Authority
- NL
- Netherlands
- Prior art keywords
- nmn
- resveratrol
- effects
- saw palmetto
- red ginseng
- Prior art date
Links
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title claims abstract description 20
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 235000021283 resveratrol Nutrition 0.000 title claims abstract description 13
- 229940016667 resveratrol Drugs 0.000 title claims abstract description 13
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 9
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 title claims abstract 9
- 235000015872 dietary supplement Nutrition 0.000 title claims description 3
- 239000010018 saw palmetto extract Substances 0.000 title abstract description 12
- 229940068517 fruit extracts Drugs 0.000 title description 4
- 230000000694 effects Effects 0.000 claims abstract description 8
- 230000008092 positive effect Effects 0.000 claims abstract description 6
- 230000037209 prostate health Effects 0.000 claims abstract description 6
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims abstract description 5
- 230000017531 blood circulation Effects 0.000 claims abstract description 5
- 230000036737 immune function Effects 0.000 claims abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 4
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 4
- 230000036039 immunity Effects 0.000 claims abstract 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract 3
- 229940018044 saw palmetto fruit extract Drugs 0.000 claims abstract 3
- 210000004556 brain Anatomy 0.000 claims abstract 2
- 208000010125 myocardial infarction Diseases 0.000 claims abstract 2
- 230000003449 preventive effect Effects 0.000 claims abstract 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 5
- 230000007423 decrease Effects 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 230000002438 mitochondrial effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000035882 stress Effects 0.000 claims description 3
- 238000013459 approach Methods 0.000 claims description 2
- 230000037149 energy metabolism Effects 0.000 claims description 2
- 238000013467 fragmentation Methods 0.000 claims description 2
- 238000006062 fragmentation reaction Methods 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 210000003470 mitochondria Anatomy 0.000 claims description 2
- 230000001991 pathophysiological effect Effects 0.000 claims description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims 3
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims 2
- 230000036772 blood pressure Effects 0.000 claims 1
- 230000003920 cognitive function Effects 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- 230000009760 functional impairment Effects 0.000 claims 1
- 230000036541 health Effects 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 230000007958 sleep Effects 0.000 claims 1
- 238000005728 strengthening Methods 0.000 claims 1
- 210000001550 testis Anatomy 0.000 claims 1
- 229960003604 testosterone Drugs 0.000 claims 1
- 230000004218 vascular function Effects 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
- 239000011701 zinc Substances 0.000 abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000007407 health benefit Effects 0.000 abstract 1
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 229940063845 saw palmetto extract Drugs 0.000 abstract 1
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 description 23
- 241000282414 Homo sapiens Species 0.000 description 8
- 240000006661 Serenoa repens Species 0.000 description 8
- 235000005318 Serenoa repens Nutrition 0.000 description 8
- 229950006238 nadide Drugs 0.000 description 7
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 5
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 206010060862 Prostate cancer Diseases 0.000 description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229940091251 zinc supplement Drugs 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010071289 Lower urinary tract symptoms Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 229960001009 acetylcarnitine Drugs 0.000 description 1
- 210000003486 adipose tissue brown Anatomy 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020934 caloric restriction Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000023549 cell-cell signaling Effects 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 230000010034 metabolic health Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 description 1
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000003845 vascular endothelial function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Zink (Zn) (1) has proven positive effects on immunity, while red ginseng (2) has been proven to improve immune function and healthy blood flow. Saw palmetto fruit extract (3) can help with maintaining prostate health. In a preclinical and clinical studies, nicotine amide mononucleotide (NMN) (4) has been associated with properties such as anti-aging, cardio and brain protection, while animal studies are confirming its potential for lifespan extension. Recent studies of resveratrol (5) have shown its preventive effects for cardiovascular diseases and stroke, potential for lifespan extension and is associated with numerous health benefits. Healthy food supplement, containing a combination of Zinc (Zn) (1), red ginseng (2), saw palmetto extract (3), nicotinamide mononucleotide (NMN) (4) and resveratrol (5) should have strong effects on maintaining prostate health, boosting immunity and maintaining healthy blood flow.
Description
Short Title Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement
Discussion While positive effects of Zine (Zn) (1), red ginseng (2), saw palmetto fruit extracts (3) have been known for centuries, NMN (4) and resveratrol (5) are getting in the focus in the last years.
As this is a novel combination, below are presented effects of each of these products individually. Zinc (Zn) (1) Zinc is a nutrient that plays many vital roles in human body. Because body doesn’t naturally produce zinc, we must obtain it through food or supplements.
Zinc is essential for cell growth and division, immune function, enzyme reactions, DNA synthesis and protein production.
Zinc helps keep your immune system strong. Because it is necessary for immune cell function and cell signalling, a deficiency can lead to a weakened immune response. Zinc supplements stimulate particular immune cells and reduce oxidative stress.
A review of seven studies demonstrated that 80-92 mg per day of zinc may reduce the length of the common cold by up to 33%. What’s more, zinc supplements significantly reduce the risk of infections and promote immune response in older adults.
Red Ginseng (2) Korean red ginseng has been used in traditional Chinese medicine as an overall wellness supplement for centuries. It has been used to: boost the immune system, improve heart health, treat diabetes, increase energy, decrease stress, treat impotence.
Korean FDA has approved it for use for improving immune function and for maintaining healthy blood flow.
Saw palmetto fruit extracts (3) Saw palmetto (Serenoa repens) is a type of palm native to the south-eastern United States. The berries of the plant are commonly used in supplements to improve prostate health, balance hormone levels, and prevent hair loss in men. It’s also associated with other benefits, including decreased inflammation and improved urinary function.
Saw palmetto may improve urinary symptoms associated with benign prostate hyperplasia (BPH) — a condition that causes an enlargement of the prostate gland and results in decreased urine flow. One 12-week study in 92 men showed that taking two capsules daily of Prostataplex, a mix of herbal supplements that include saw palmetto, helped improve urinary tract symptoms associated with BPH. Similarly, another study in 85 men over the age of 45 found that treatment with 160 mg of saw palmetto twice daily reduced lower urinary tract symptoms, increased urine flow, and improved overall quality of life after 6 months.
Some research suggests that saw palmetto could support prostate health and may aid in preventing issues like BPH and prostate cancer. According to one test-tube study, saw palmetto berry extract was able to decrease the growth of prostate cancer cells.
Another test-tube study showed that saw palmetto blocked the spread and growth of prostate cancer cells by deactivating specific receptors involved in cancer development. NMN (Nicotinamide Mononucleotide) Molecule (4) NMN naturally exists in avocadoes, tomatoes, cucumber, cabbages, broccoli, and raw beef. In the laboratory, it is available as nicotinamide mononucleotide bulk powder.
In the human body, NMN is the principal source of energy within the cells. As we age, cellular energy decreases due to the low levels of nicotinamide mononucleotide and subsequent reduction of NAD. Administering NMN will reverse the process and compensate for the deficit.
NMN exists in both alpha (a) and beta (B) forms. However, B-NMN is the most active form. This bioactive nucleotide is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide or NAD. FDA recommends that any human being needs approximately 560 mg of NMN per day.
Human Clinical Trials with NMN There are 113 ongoing clinical trials in humans that are investigating NAD precursors (NMN, - NR and Niacin), majority of them are not completed and only few have results published. The most important study in humans was a study in Japanese man, that showed that the single oral administration of NMN up to 500 mg was safe and well-tolerated in healthy men without causing any significant deleterious effects. It has demonstrated that the oral administration of NMN is feasible and could be a therapeutic strategy to replenish cellular - NAD" levels to mitigate aging-related functional disorders in humans.
- Trials in humans with results are: o An international collaborative team including researchers from Keio University in Tokyo and Washington University School of Medicine in St. Louis is running a Phase | human clinical study of NMN in Japan.
o Clinical trials examining the safety and efficacy of NMN are also currently being run at Washington University, investigating the effect on insulin sensitivity, endothelial function, lipids, body and liver fat and markers of cardiovascular and metabolic health.
o Arandomized, double-blind, three-arm crossover pharmacokinetic study in 12 human subjects showed that NR raises NAD+ by as much as 2.7-fold in human blood with a single oral dose of 1000 mg.
o Researchers at the University of Washington have completed a clinical trial with 140 participants showing that orally administered NR gives a dose dependent increase in NAD+ from 250-1000 mg/d plateauing at a 2-fold increase in NAD+ at day nine.
o Researchers have also reported positive effects of NR on vascular endothelial function in healthy middle-aged and older adults, with further investigations of motor and cognitive changes to come.
o Recently, researchers have found that a resveratrol analog called pterostilbene combined with NR seemed to help ALS/Lou Gehrig's patients.
o Most recently, a placebo-controlled study assessing 500 mg of NR, taken twice daily by 70- to 80-year olds, showed increases in NAD+ in blood (but not muscle.) Inflammation fell and, unexpectedly, mitochondrial activity did too.
o Multiple other studies are now underway assessing the effects of NR on muscie mitochondrial function, cognition, immune function, kidney function, traumatic brain injury, brown fat activity, lipid accumulation, energy metabolism, cardiovascular risk, body composition, and acetylcarnitine levels.
Clinical trials results should be available in the new few years. What we can claim with certainly at this moment, based on clinical research data is that NMN is safe and well-tolerated in healthy men and that it is able to successfully replenish cellular NAD+ levels. And we know that decline in NAD levels is associated with aging.
NMN Animal Studies - Animal studies are confirming that the pharmacological activities of NMN include its role in cellular biochemical functions, cardio protection, diabetes, Alzheimer’s disease, and complications associated with obesity. The recent groundbreaking discovery of anti-ageing activities of this chemical moiety has added a valuable essence in the research involving this molecule.
- Studies confirmed that manipulation of mitochondrial NAD levels by NMN results in metabolic changes that protect mitochondria against reactive oxygen species and excessive fragmentation, offering therapeutic approaches for pathophysiologic stress conditions.
Resveratrol (5) Resveratrol is a nutrient found abundantly in the skin of red grapes that is known to have robust antioxidant and anti-inflammatory properties.
The efficacy, safety, and pharmacokinetics of Resveratrol have been documented in over 244 clinical trials, with an additional 27 clinical trials currently ongoing.
Resveratrol has various biochemical and physiological effects such as anti-inflammatory, antioxidative, antiproliferative and chemo-preventive effects.
Recent studies have shown its positive effects especially on cardiovascular diseases, cancer, type 2 diabetes and neurological disorders.
Resveratrol is reported to potentially improve the therapeutic outcome in patients suffering from diabetes mellitus, obesity, colorectal cancer, breast cancer, multiple myeloma, metabolic syndrome, hypertension, Alzheimer's disease, stroke, cardiovascular diseases, kidney diseases, inflammatory
5 diseases, and rhinopharyngitis.
It was also proven that it mimics caloric restriction, which has numerous positive effects.
Resveratrol is reported to be safe at doses up to 5 g/d. when used either alone or as a combination therapy. /
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1043752 | 2020-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL1044086A true NL1044086A (en) | 2022-04-04 |
NL1044086B1 NL1044086B1 (en) | 2023-10-20 |
Family
ID=80998221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL1044086A NL1044086B1 (en) | 2020-08-12 | 2021-07-06 | Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement |
Country Status (1)
Country | Link |
---|---|
NL (1) | NL1044086B1 (en) |
-
2021
- 2021-07-06 NL NL1044086A patent/NL1044086B1/en active
Also Published As
Publication number | Publication date |
---|---|
NL1044086B1 (en) | 2023-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7210459B2 (en) | Antiaging agent and antiaging method | |
EP2491938B1 (en) | Formulations for well-being | |
EP3850954A1 (en) | Anti-aging agent and anti-aging method | |
CN1970007A (en) | Capsule for improving sexual function for men | |
WO2008095093A2 (en) | Method of increasing cellular function and health of glutathione deficient animals | |
NL1044086B1 (en) | Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement | |
JP2009013083A (en) | Orally administerable composition | |
ITRM20130655A1 (en) | PRODUCT BASED ON AN ASSOCIATION OF GLUCOMANNAN AND INOSITLE | |
CN108186631B (en) | Pharmaceutical composition and preparation method and application thereof | |
NL1044087B1 (en) | Combination of Vitamin C, red ginseng, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement)) | |
NL1044090B1 (en) | Combination of vitamin B6, ginseng, green tea extract, Ganoderma lucidum, black cohosh root, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement) | |
NL1044088B1 (en) | Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food (Dietary Supplement) | |
Votano et al. | Importance of Alpha Lipoic Acid (ALA): Antidiabetic and Antioxidant Effects | |
NL1044089B1 (en) | Combination of Vitamin C, red ginseng, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement)) | |
EP3750532A1 (en) | A food supplement for use in restoring male sex drive (libido) | |
RU2553374C1 (en) | Method for increasing body adaptability under thermal stress | |
CN109674972A (en) | The application of month peach essential oil | |
Marietta et al. | The supplementation effect of Red Dragon fruit's skin extract on the fasting blood glucose and lipid profiles in male Wistar rats with diabetes mellitus and dyslipidemia | |
WO2006007818A2 (en) | Method for systemic bio-correction of an organism | |
EP4311553A1 (en) | Method for preparing gynostemma pentaphyllum leaf extract and gynostemma pentaphyllum leaf extract prepared thereby | |
WO2023182529A1 (en) | Pharmaceutical composition | |
CN111838669B (en) | Nano composition for treating and improving vulnerable viscera, preparation method and application | |
CN112386601B (en) | Vitamin D supplement preparation and application thereof | |
Talukder | What to do with placenta after birth: is it a waste? | |
US20230346751A1 (en) | Compositions and methods for treatment of skin-related diseases and promoting dermatological health |